Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

First Patients Enrolled in Groundbreaking Brain Cancer Study at Nationally Recognized Academic Medical Center

Exvade Bioscience(tm), a clinical-stage neuro-oncology company advancing a breakthrough platform for treating aggressive brain cancers, today highlighted ongoing enrollment in a Phase 1 clinical trial (NCT04547777) at the Preston Robert Tisch Brain Tumor Center at Duke University.

January 6, 2026


January 7 2026

January 6 2026

January 5 2026

January 4 2026

January 3 2026

January 2 2026

January 1 2026

December 31 2025

December 30 2025

December 29 2025

December 28 2025

December 27 2025

December 26 2025

December 24 2025